RECENT NEWS

The UK’s clinical immunology and allergy workforce is under severe strain, with consultant shortages leaving some services extremely fragile, according to a new report by the British Society for Immunology Clinical Immunology Professional Network (BSI-CIPN).

A study of the human nasal microbiome has allowed scientists to rethink how bacterial communities interact in the nose.

The Department of Health and Social Care (DHSC) has published its HIV Action Plan for England, 2025 to 2030, which sets out how the government will reach its ambition of ending new HIV transmissions by 2030.

The Institute of Cancer Research (ICR), has responded to the draft recommendation from the National Screening Committee (NSC) to implement a targeted prostate cancer screening programme for men with a confirmed BRCA1 and BRCA2 variant.

The UK National Screening Committee (NSC) has opened a public consultation on prostate cancer screening, following its decision to not recommend population screening.

A new study led by the University of Cambridge and the University of Glasgow has discovered that bird influenza viruses are a particular threat to humans because they can replicate at temperatures higher than a typical fever, one of the body’s ways of stopping viruses in their tracks.

Baroness Nicola Blackwood has been appointed as Chair of the Health Data Research Service (HDRS) a new service which aims to streamline NHS data access for approved researchers to develop new medicines and therapies.

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel mRNA-based therapy designed to combat antibiotic-resistant bacteria.

Innotive Diagnostics has successfully won a £1m grant from PACE (Pathways to Antimicrobial Clinical Efficacy) to advance the development of its rapid urinary tract infection (UTI) point of care diagnostics system and InnotiveUTI test.

A major new study led by Imperial College London and supported by the Medicines and Healthcare products Regulatory Agency (MHRA) has uncovered critical insights into the spread patterns of vaccine-derived poliovirus type 2 (cVDPV2), offering valuable intelligence to support global efforts to eradicate polio.

A national digital learning academy, designed to strengthen pathology education and training, has launched in Wales.

A hospital-acquired bacterium that causes serious infections can move from the lungs to the gut inside the same patient, raising the risk of life-threatening sepsis, new research reveals.

The Chancellor will double down on the government’s commitment of continuing to slash NHS waiting times in the Autumn Budget - confirming the investment for hundreds of new Neighbourhood Health Centres that will deliver healthcare direct to people’s doorsteps across the country.

Leica Biosystems has announced a new strategic partnership with L7 Informatics, a pioneer in data unification and workflow orchestration for life sciences, to advance leading pathology informatics.

Patients with an aggressive form of leukaemia will be able to receive a breakthrough immunotherapy on the NHS that saw over three-quarters of patients go into remission in trials.

A new report published by The Royal College of Pathologists (RCPath) highlights the crisis facing paediatric and perinatal pathology, with long waits for post-mortem reports and only 3% of consultants believing that current staffing levels are adequate to ensure the long-term sustainability of their service.

Manchester’s position as a leading UK life sciences hub has taken a major step forward, as UK Biobank begins the fit-out of its new national headquarters at Bruntwood SciTech’s Greenheys - a purpose-built development at the heart of Manchester Science Park, due to complete in summer 2026.

The first men are being recruited to a landmark trial kicking off the biggest prostate cancer screening study in a generation. The £42m TRANSFORM screening trial is co-funded by Prostate Cancer UK (PCUK) and the National Institute for Health and Care Research (NIHR), and is the most ambitious prostate cancer study in decades.

Abbott has announced it is to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, in a deal worth around US$21billion.

Rapid diagnostic firm OCEAN Dx has announced the successful completion of a clinical evaluation study for its innovative rapid diagnostic test for sepsis, which shows it achieved results consistent with the gold standard for sepsis detection.